candidiasis-candida-antifungal-natural-protocol-2026">Candida albicans (intestinal, oral, vaginal, and in severe cases systemic) is promoted by 4 factors: broad-spectrum antibiotics, immunosuppression, excessive sugar, bacterial dysbiosis. Central mechanism: Candida albicans -> hyphae (invasive filamentous form) -> mucosal perforation -> beta-glucan + mannan -> TLR2/Dectin-1 -> NF-kB + NLRP3-inflammasome -> IL-1beta, IL-18 -> systemic inflammation. Sugar is Candida's direct fuel: in a glucose-rich environment, Candida switches from the yeast (commensal) to the hyphal (invasive) form -- this morphological switch is NF-kB-dependent in the host. 6-Gingerol: (1) direct antifungal (ergosterol membrane disruption, MIC 125-250 ug/mL), (2) Candida biofilm inhibition -65%, (3) reduced NF-kB/NLRP3 in macrophages, (4) restores Lactobacillus/Bifidobacterium which compete with Candida. GIMBER = food for Candida: 35g sugar/100ml -> glucose -> Candida hyphae -> invasion -> IL-1beta -> systemic NF-kB. INTI: 1.19g sugar/100ml.
Candida albicans & NF-kB: the sugar-induced yeast-hypha switch
Candida albicans is a normal commensal of the digestive tract (present in 70-80% of healthy individuals at low density). In a glucose-rich microenvironment, Candida expresses virulence genes (EFG1, HWP1, ALS3) that convert the harmless round yeast cell into an invasive filamentous hypha capable of perforating the intestinal epithelium. This morphological switch is accelerated by glucose (direct inducer of the cAMP/PKA/EFG1 pathway) -- which explains why patients on glucose-rich parenteral nutrition, or who consume large amounts of sugar, have more severe and invasive candidiases.
| Factor | Effect on Candida | Host NF-kB | Gingerol |
|---|---|---|---|
| Increased glucose (GIMBER!) | Yeast -> invasive hyphae (cAMP/PKA) | Beta-glucan -> TLR2 -> NF-kB | Sugar down (-4g vs 35g) |
| Dysbiosis (Lactobacillus down) | Candida overgrowth non-competitive | LPS/Candida -> composite NF-kB | Lactobacillus restoration + |
| Candida biofilm (CaCDR1/ERG11) | Antifungal resistance x100-1000 | NLRP3 -> chronic IL-1beta | Biofilm -65% in vitro |
| Mannoprotein surface | Dectin-1 -> NLRP3 -> IL-18 | Systemic NLRP3-inflammasome | NLRP3 -38% (6-gingerol) |
GIMBER = automatic Candida feeder
- Each GIMBER shot brings 35g sugar -> glucose -> cAMP/PKA -> Candida virulence genes activated
- Fructose promotes Candida growth even more than glucose (fructose-1,6-bisphosphate pathway)
- Sugar -> dysbiosis -> less Lactobacillus -> less competition -> Candida proliferates
- Sugar -> transient immunosuppression (neutrophil TNF-alpha production -50% for 5h after glycemic peak)
INTI: 1.19g sugar/100ml. Candida starved. Active anti-biofilm.
Protocol Candida terrain with INTI
| Situation | INTI protocol | Goal |
|---|---|---|
| Antibiotic treatment | 1-2 INTI/day + probiotics | Lactobacillus restoration, anti-Candida |
| Prevention of vaginal recurrence | 1 INTI/day continuously | Candida biofilm -65%, glycemia stable |
| Persistent intestinal Candida | INTI + anti-candida diet | NF-kB/NLRP3, Candida starved |
Is the "anti-candida diet" scientifically proven?
Partially. Eliminating refined sugar is supported by solid in vitro data (Candida grows on glucose) and observational studies. Eliminating gluten and dairy, often recommended in "Candida protocols," has a weaker scientific basis. The most valid anti-Candida diet is: zero refined sugar + Lactobacillus probiotics + antifungals if necessary + ginger shot without sugar without sugar (anti-biofilm/anti-NF-kB).
Symptoms of intestinal Candida: how to recognize?
"Systematized intestinal Candida" as described in popular literature (chronic fatigue, brain fog, bloating) is not a recognized diagnosis in conventional medicine, except in immunocompromised patients. Digestive symptoms (bloating, altered bowel movements) may be due to general intestinal dysbiosis rather than specifically Candida. If Candida is suspected, a copro-mycological examination with culture can be requested.
1.19g sugar/100ml | Biofilm -65% | NLRP3 -38% | Lactobacillus +
Discover INTI
Related articles
Read more about related topics :
- Bipolar Disorder Belgium 2025: NF-kB Neuronal, GSK-3beta & Ginger
- hashimoto-<a%20href=" https:>thyroiditis-belgie-nfkb-tpo-microbioom-gember-2025">ginger Hashimoto Belgium 2025: NF-kB Thyroiditis, TPO Antibodies & Ginger
- Ginger and cancer prevention: what science says — and why GIMBER sugar sabotages it
- ginger candidiasis Systemic Belgium 2025: NF-kB Candida, NLRP3 & Ginger
- ginger diabetic neuropathy Small Fibers Belgium 2025: NF-kB Neuronal, TRPV1 & Ginger
- Active Ulcerative Colitis Belgium 2025: NF-kB Colonocytes, IL-33 & Ginger
- ginger Crohn-disease-belgie-nfkb-intestinal-tnf-alpha-ginger-2025">Active Crohn's Disease Belgium 2025: NF-kB Intestinal, TNF-alpha & Ginger
- fibromyalgia-advanced-belgium-nfkb-glial-central-sensitization-ginger-2025">Advanced Fibromyalgia Belgium 2025: NF-kB Glial, Central Sensitization & Ginger
Recommended pages
Explore more about INTI :